ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullishSamsung SDS
08 Aug 2018 15:51

Samsung Group Plans to Invest 180 Trillion Won in the Next Three Years

The Samsung Group announced a major plan today to invest 180 trillion won (about US$160 billion) in the next three years, including in major...

Logo
453 Views
Share
bearishCelltrion Inc
08 Aug 2018 03:59

Celltrion: Manufacturing Risks Remain

Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...

Share
bullishSK Inc
14 Jul 2018 10:38

SK Holdings (034730 KS): AMPAC Acquisition - Summary & Ramifications

SK Holdings Co Ltd (034730 KS) said in a regulatory filing that it had acquired a 100% stake in Fine Chemicals Holdings Corp. which is the parent...

Logo
824 Views
Share
13 Jul 2018 01:56

Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications

This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...

Logo
956 Views
Share
12 Jul 2018 17:44

Samsung Biologics: Regulators Crack Down On Its Accounting

After the market close today, the Korean regulators (Financial Services Commission) made a major negative announcement on Samsung Biologics Co.,...

Logo
522 Views
Share
x